Home > Qtrly Results > BETA DRUGS

BETA DRUGS
Quarterly Results Analysis [Sep2026]

BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Quarterly Results

Consolidated Sep2026
UnAudited
Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
Audited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
Audited
Revenues ₹137 Cr ₹126 Cr ₹94 Cr ₹87 Cr ₹103 Cr ₹100 Cr ₹94 Cr ₹88 Cr
Expenses ₹107 Cr ₹98 Cr ₹76 Cr ₹70 Cr ₹82 Cr ₹81 Cr ₹76 Cr ₹70 Cr
Operating Income ₹30 Cr ₹27 Cr ₹18 Cr ₹17 Cr ₹21 Cr ₹20 Cr ₹17 Cr ₹18 Cr
Other Income ₹2 Cr ₹2 Cr ₹3 Cr ₹2 Cr ₹3 Cr ₹3 Cr ₹4 Cr ₹1 Cr
Interest ₹2 Cr ₹3 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹3 Cr ₹3 Cr ₹2 Cr
Depreciation ₹5 Cr ₹4 Cr ₹5 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹3 Cr
Profit Before Tax ₹26 Cr ₹22 Cr ₹12 Cr ₹10 Cr ₹16 Cr ₹16 Cr ₹12 Cr ₹12 Cr
Profit After Tax ₹19 Cr ₹16 Cr ₹9 Cr ₹9 Cr ₹12 Cr ₹12 Cr ₹9 Cr ₹9 Cr
EPS ₹16.68 ₹14.25 ₹8.93 ₹8.40 ₹12.10 ₹11.59 ₹8.95 ₹8.86
Industry Peers & Returns1W1M1Y
BETA DRUGS 1.8% 9.6% 12%
SUN PHARMACEUTICAL INDUSTRIES 1.4% 6.7% 12%
DIVIS LABORATORIES 11.1% 23.5% 70%
TORRENT PHARMACEUTICALS 1% 1.8% 34.3%
CIPLA 0.1% 6% -5.8%
DR REDDYS LABORATORIES 1.1% 11.8% 14.2%
MANKIND PHARMA 3.7% 11.2% 17.4%
LUPIN 1.2% 2.8% 2.5%
ZYDUS LIFESCIENCES -0.5% 4.5% 29.6%

BETA DRUGS Quarterly Revenues

Revenues
Q-o-Q

9.51 %

Y-o-Y

32.99 %

Quarters Revenues % Change
Sep2026 ₹137 Cr
9.51
Jun2026 ₹126 Cr
33.61
Mar2026 ₹94 Cr
7.67
Dec2025 ₹87 Cr
-15.59
Sep2025 ₹103 Cr
3.17
Jun2025 ₹100 Cr
6.87
Mar2025 ₹94 Cr
6.20
Dec2024 ₹88 Cr -

BETA DRUGS Quarterly Operating Profit

Operating Profit
Q-o-Q

10.64 %

Y-o-Y

42.11 %

Quarters Operating Profit % Change
Sep2026 ₹30 Cr
10.64
Jun2026 ₹27 Cr
54.81
Mar2026 ₹18 Cr
4.08
Dec2025 ₹17 Cr
-20.28
Sep2025 ₹21 Cr
8.13
Jun2025 ₹20 Cr
13.61
Mar2025 ₹17 Cr
-6.00
Dec2024 ₹18 Cr -
Operating Margins
Q-o-Q

1.01 %

Y-o-Y

6.84 %

Quarters Operating Margin% % Change
Sep2026 22.02%
1.01
Jun2026 21.8%
15.90
Mar2026 18.81%
-3.34
Dec2025 19.46%
-5.58
Sep2025 20.61%
4.83
Jun2025 19.66%
6.27
Mar2025 18.5%
-11.48
Dec2024 20.9% -

BETA DRUGS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

16.99 %

Y-o-Y

57.84 %

Quarters Profit After Tax % Change
Sep2026 ₹19 Cr
16.99
Jun2026 ₹16 Cr
82.15
Mar2026 ₹9 Cr
6.26
Dec2025 ₹9 Cr
-30.29
Sep2025 ₹12 Cr
4.44
Jun2025 ₹12 Cr
29.50
Mar2025 ₹9 Cr
0.97
Dec2024 ₹9 Cr -
PAT Margins
Q-o-Q

6.85 %

Y-o-Y

18.70 %

Quarters PAT Margin(%) % Change
Sep2026 14.03 %
6.85
Jun2026 13.13 %
36.34
Mar2026 9.63 %
-1.33
Dec2025 9.76 %
-17.43
Sep2025 11.82 %
1.29
Jun2025 11.67 %
21.18
Mar2025 9.63 %
-4.94
Dec2024 10.13 % -

BETA DRUGS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

17.05 %

Y-o-Y

37.85 %

Quarters EPS % Change
Sep2026 ₹16.68
17.05
Jun2026 ₹14.25
59.57
Mar2026 ₹8.93
6.31
Dec2025 ₹8.4
-30.58
Sep2025 ₹12.1
4.40
Jun2025 ₹11.59
29.50
Mar2025 ₹8.95
1.02
Dec2024 ₹8.86 -

You may also like the below Video Courses